Drug Interaction Between Amiodarone and Antitubercular Drugs

Critical Pharmacokinetic Considerations

• The extremely long half-life of amiodarone (averaging 58 days) means drug interactions can persist for months after discontinuation, as noted by the American Academy of Family Physicians 1, 2

Specific Antitubercular Drug Interactions

• Rifabutin is a moderate P-glycoprotein and CYP3A4 inducer, which can reduce amiodarone exposure and effectiveness, according to the Journal of Hepatology 3, 4
• Other potential interactions may occur with moderate inducers such as rifabutin, oxcarbazepine, rifapentine, and modafinil, as reported by the Journal of Hepatology 3, 4

Clinical Management Algorithm

• If a patient on amiodarone requires tuberculosis treatment, rifabutin should be avoided if possible, though less potent than rifampin, it still poses risk, as noted by the Journal of Hepatology 3, 4
• Consider discontinuing amiodarone 3 months before starting rifampin, accounting for amiodarone's long half-life, as suggested by the Journal of Hepatology 3, 4

Additional Monitoring Considerations

• Baseline and ongoing monitoring should include thyroid function, liver enzymes, and pulmonary function, as recommended by the American Academy of Family Physicians 1
• Amiodarone-induced lung toxicity can mimic or mask tuberculosis, making diagnosis challenging, and chest imaging may be confounded by amiodarone pulmonary toxicity, which can present similarly to TB, as noted by the American Academy of Family Physicians 1

Critical Pitfalls to Avoid

• Underestimating the duration of amiodarone's effects after discontinuation, interactions persist for months due to tissue accumulation, as warned by the American Academy of Family Physicians and Praxis Medical Insights 1, 2